Product Program year 2025 Source: CMS Open Payments

Bludigo

Drug Marker dye

NDC 81284-315-05

Open in the dashboard

General payments

$136,372

301 payments

Research payments

$1,330,428

100 payments

Through program year 2025, $136,372 in general payments and $1,330,428 in research payments were reported against Bludigo (Marker dye).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $109,759 195
2025 Research $635,663 53
2024 General $26,613 106
2024 Research $694,765 47

Breakdown

Who paid General payments · program years 2024–2025
  1. Provepharm Inc. $136,372 301 payments
Top recipients General payments · program year 2025
  1. Suzanne Gagnon Internal Medicine · North Wales, PA $92,700 84% · 21 payments
  2. Charles Ascher-Walsh Gynecology · New York, NY $8,767 8% · 3 payments
  3. Sandip Vasavada Urology · Cleveland, OH $1,600 1% · 2 payments
  4. Kelly Wright Gynecology · Los Angeles, CA $1,475 1% · 1 payment
  5. Matthew Barker Urogynecology and Reconstructive Pelvic Surgery · Sioux Falls, SD $1,380 1% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Internal Medicine $92,728 85% · 3 practitioners
  2. Gynecology Obstetrics & Gynecology $10,326 9% · 6 practitioners
  3. Urology $2,437 2% · 43 practitioners
  4. Urogynecology and Reconstructive Pelvic Surgery Obstetrics & Gynecology $2,317 2% · 16 practitioners
  5. Obstetrics & Gynecology $795 <1% · 41 practitioners

The top 5 of 20 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Pennsylvania $92,914 85% · 12 recipients
  2. New York $9,571 9% · 11 recipients
  3. California $1,696 2% · 12 recipients
  4. Ohio $1,654 2% · 4 recipients
  5. South Dakota $1,380 1% · 1 recipient

The top 5 of 27 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

301 general · 100 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record